+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Peripheral Vascular Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 249 Pages
  • July 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5924996
The global peripheral vascular devices market size is likely to be valued at US$ 5.9 Bn in 2025 and is estimated to reach US$ 9.5 Bn by 2032, growing at a CAGR of 7.04% during the forecast period from 2025 to 2032. The market is experiencing steady growth due to the rising prevalence of peripheral artery disease, growing demand for minimally invasive procedures, and technological advancements in vascular intervention. Increasing geriatric population and associated vascular disorders are further driving the adoption of peripheral vascular devices across healthcare facilities worldwide.

Peripheral Vascular Devices Market - Report Scope:

The peripheral vascular devices market includes a broad spectrum of medical devices used to treat conditions affecting blood vessels outside of the heart and brain. These include stents, catheters, balloons, and scaffolds used in endovascular procedures to restore proper blood flow. With growing global burden of lifestyle-related conditions like diabetes and obesity, demand for effective vascular solutions has intensified. The market is also being shaped by ongoing innovation in bioresorbable scaffolds, drug-eluting technologies, and image-guided catheterization tools.

Key Market Drivers:

One of the primary drivers of the peripheral vascular devices market is the increasing incidence of peripheral artery disease (PAD) globally. Aging populations, sedentary lifestyles, and rising rates of smoking and diabetes are contributing to vascular health deterioration. Advancements in device technologies, including drug-coated balloons and bioresorbable vascular scaffolds, are enhancing clinical outcomes and boosting adoption. In addition, increasing preference for minimally invasive endovascular procedures over traditional surgery is propelling market demand. Government initiatives and healthcare spending aimed at improving vascular health are further supporting market expansion.

Market Restraints:

Despite significant growth potential, the peripheral vascular devices market faces challenges such as high treatment costs and limited access in low- and middle-income regions. Reimbursement complexities in some countries can hinder the adoption of advanced vascular devices. Additionally, the risk of restenosis, device failure, and procedure-related complications continues to raise concerns among both patients and physicians. Regulatory hurdles for new product approvals and pricing pressures from healthcare systems may also slow down market penetration.

Emerging Business Opportunities:

The market offers notable opportunities for manufacturers focusing on next-generation vascular devices that deliver enhanced safety and efficacy. Growth in emerging economies such as India, China, Brazil, and Southeast Asia, driven by increasing healthcare infrastructure and awareness, presents a lucrative expansion landscape. Collaborations with healthcare providers and investments in clinical trials can help validate device performance and accelerate market entry. The increasing role of AI and advanced imaging in vascular interventions also offers potential for differentiation and innovation in procedural precision.

Regional Outlook:

North America holds a dominant share in the global peripheral vascular devices market, supported by a well-established healthcare infrastructure, high prevalence of PAD, and early adoption of advanced vascular technologies. Europe follows closely, with countries like Germany, France, and the UK showing strong demand for minimally invasive vascular procedures. The Asia Pacific region is expected to witness the fastest growth due to increasing chronic disease burden, aging population, and expanding access to interventional care. Meanwhile, Latin America and the Middle East & Africa are gradually emerging as promising markets with rising investments in healthcare modernization.

Leading Companies:

Leading companies in the global peripheral vascular devices market, such as Abbott Laboratories, Boston Scientific Corporation, and Medtronic Plc, are actively engaged in product development, clinical innovation, and strategic acquisitions to strengthen their market position. Firms are focusing on creating flexible, deliverable, and drug-eluting platforms that reduce restenosis risk and improve long-term patient outcomes. Collaborations with hospitals and catheterization labs, along with robust after-sales support, are key elements of their expansion strategies.

Companies Covered in This Report:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation (Endovastec™)
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Becton, Dickinson, and Company
  • W. L. Gore & Associates Inc.
  • Getinge AB
  • Terumo Corp
  • Kyoto Medical Planning Co Ltd
  • iVascular S.L.U
  • AMG International GmbH
  • ENDOCOR GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Nano Therapeutics Pvt Ltd
  • Koninklijke Philips N.V.
  • REVA Medical

Market Segmentation:

By Product:

  • Peripheral Vascular Stents
  • Self-Expanding Stents
  • Balloon Expanding Stents
  • Covered Stents
  • Drug Eluting Stents
  • Drug Eluting Balloons
  • Peripheral Vascular Bioresorbable Scaffolds

By Indication:

  • Target Artery Instability (TAI)
  • Access Artery Injury (AAI)
  • Peripheral Arterial Disease
  • Arteriovenous Fistulas
  • Peripheral Aneurysms
  • Others

By Artery Type:

  • Carotid Artery
  • Fem-Pop Artery
  • Iliac Artery
  • Infrapop Artery

By End User:

  • Hospitals
  • Ambulatory Surgical Centers/Outpatients
  • Cardiac Catheterization Labs

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Peripheral Vascular Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2019-2024
3.1. Global Peripheral Vascular Devices Market Production Output, by Region, Value (US$ Bn) and Volume (Units), 2019-2024
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2019-2024
4.1. Global Average Price Analysis, by Product/ Material, US$ Per Unit, 2019-2024
4.2. Prominent Factor Affecting Peripheral Vascular Devices Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Peripheral Vascular Devices Market Outlook, 2019-2032
5.1. Global Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Peripheral Vascular Stents
5.1.1.1.1. Self-Expanding Stents
5.1.1.1.2. Balloon Expanding Stents
5.1.1.1.3. Covered Stents
5.1.1.1.4. Drug Eluting Stents
5.1.1.2. Drug Eluting Balloons
5.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
5.2. Global Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Target Artery Instability (TAI)
5.2.1.2. Access Artery Injury (AAI)
5.2.1.3. Peripheral Arterial Disease
5.2.1.4. Arteriovenous Fistulas
5.2.1.5. Peripheral Aneurysms
5.2.1.6. Others
5.3. Global Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Carotid Artery
5.3.1.2. Fem-Pop Artery
5.3.1.3. Iliac Artery
5.3.1.4. Infrapop Artery
5.4. Global Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Ambulatory Surgical Centers/Outpatients
5.4.1.3. Cardiac Catheterization Labs
5.5. Global Peripheral Vascular Devices Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019-2032
5.5.1. Key Highlights
5.5.1.1. North America
5.5.1.2. Europe
5.5.1.3. Asia Pacific
5.5.1.4. Latin America
5.5.1.5. Middle East & Africa
6. North America Peripheral Vascular Devices Market Outlook, 2019-2032
6.1. North America Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Peripheral Vascular Stents
6.1.1.1.1. Self-Expanding Stents
6.1.1.1.2. Balloon Expanding Stents
6.1.1.1.3. Covered Stents
6.1.1.1.4. Drug Eluting Stents
6.1.1.2. Drug Eluting Balloons
6.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
6.2. North America Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Target Artery Instability (TAI)
6.2.1.2. Access Artery Injury (AAI)
6.2.1.3. Peripheral Arterial Disease
6.2.1.4. Arteriovenous Fistulas
6.2.1.5. Peripheral Aneurysms
6.2.1.6. Others
6.3. North America Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Carotid Artery
6.3.1.2. Fem-Pop Artery
6.3.1.3. Iliac Artery
6.3.1.4. Infrapop Artery
6.4. North America Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Ambulatory Surgical Centers/Outpatients
6.4.1.3. Cardiac Catheterization Labs
6.5. North America Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
6.5.1. Key Highlights
6.5.1.1. U.S. Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
6.5.1.2. U.S. Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
6.5.1.3. U.S. Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
6.5.1.4. U.S. Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
6.5.1.5. Canada Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
6.5.1.6. Canada Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
6.5.1.7. Canada Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
6.5.1.8. Canada Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Peripheral Vascular Devices Market Outlook, 2019-2032
7.1. Europe Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Peripheral Vascular Stents
7.1.1.1.1. Self-Expanding Stents
7.1.1.1.2. Balloon Expanding Stents
7.1.1.1.3. Covered Stents
7.1.1.1.4. Drug Eluting Stents
7.1.1.2. Drug Eluting Balloons
7.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
7.2. Europe Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Target Artery Instability (TAI)
7.2.1.2. Access Artery Injury (AAI)
7.2.1.3. Peripheral Arterial Disease
7.2.1.4. Arteriovenous Fistulas
7.2.1.5. Peripheral Aneurysms
7.2.1.6. Others
7.3. Europe Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Carotid Artery
7.3.1.2. Fem-Pop Artery
7.3.1.3. Iliac Artery
7.3.1.4. Infrapop Artery
7.4. Europe Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Ambulatory Surgical Centers/Outpatients
7.4.1.3. Cardiac Catheterization Labs
7.5. Europe Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Germany Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.2. Germany Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.3. Germany Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.4. Germany Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.5. U.K. Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.6. U.K. Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.7. U.K. Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.8. U.K. Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.9. France Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.10. France Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.11. France Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.12. France Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.13. Italy Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.14. Italy Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.15. Italy Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.16. Italy Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.17. Turkey Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.18. Turkey Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.19. Turkey Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.20. Turkey Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.21. Russia Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.22. Russia Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.23. Russia Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.24. Russia Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.25. Rest of Europe Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.26. Rest of Europe Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.27. Rest of Europe Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1.28. Rest of Europe Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Peripheral Vascular Devices Market Outlook, 2019-2032
8.1. Asia Pacific Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Peripheral Vascular Stents
8.1.1.1.1. Self-Expanding Stents
8.1.1.1.2. Balloon Expanding Stents
8.1.1.1.3. Covered Stents
8.1.1.1.4. Drug Eluting Stents
8.1.1.2. Drug Eluting Balloons
8.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
8.2. Asia Pacific Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Target Artery Instability (TAI)
8.2.1.2. Access Artery Injury (AAI)
8.2.1.3. Peripheral Arterial Disease
8.2.1.4. Arteriovenous Fistulas
8.2.1.5. Peripheral Aneurysms
8.2.1.6. Others
8.3. Asia Pacific Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Carotid Artery
8.3.1.2. Fem-Pop Artery
8.3.1.3. Iliac Artery
8.3.1.4. Infrapop Artery
8.4. Asia Pacific Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Ambulatory Surgical Centers/Outpatients
8.4.1.3. Cardiac Catheterization Labs
8.5. Asia Pacific Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1. Key Highlights
8.5.1.1. China Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.2. China Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.3. China Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.4. China Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.5. Japan Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.6. Japan Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.7. Japan Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.8. Japan Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.9. South Korea Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.10. South Korea Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.11. South Korea Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.12. South Korea Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.13. India Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.14. India Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.15. India Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.16. India Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.17. Southeast Asia Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.18. Southeast Asia Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.19. Southeast Asia Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.20. Southeast Asia Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.21. Rest of Asia Pacific Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.22. Rest of Asia Pacific Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.23. Rest of Asia Pacific Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1.24. Rest of Asia Pacific Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Peripheral Vascular Devices Market Outlook, 2019-2032
9.1. Latin America Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032
9.1.1. Key Highlights
9.1.1.1. Peripheral Vascular Stents
9.1.1.1.1. Self-Expanding Stents
9.1.1.1.2. Balloon Expanding Stents
9.1.1.1.3. Covered Stents
9.1.1.1.4. Drug Eluting Stents
9.1.1.2. Drug Eluting Balloons
9.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
9.2. Latin America Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
9.2.1. Key Highlights
9.2.1.1. Target Artery Instability (TAI)
9.2.1.2. Access Artery Injury (AAI)
9.2.1.3. Peripheral Arterial Disease
9.2.1.4. Arteriovenous Fistulas
9.2.1.5. Peripheral Aneurysms
9.2.1.6. Others
9.3. Latin America Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
9.3.1. Key Highlights
9.3.1.1. Carotid Artery
9.3.1.2. Fem-Pop Artery
9.3.1.3. Iliac Artery
9.3.1.4. Infrapop Artery
9.4. Latin America Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Ambulatory Surgical Centers/Outpatients
9.4.1.3. Cardiac Catheterization Labs
9.5. Latin America Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1. Key Highlights
9.5.1.1. Brazil Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.2. Brazil Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.3. Brazil Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.4. Brazil Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.5. Mexico Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.6. Mexico Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.7. Mexico Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.8. Mexico Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.9. Argentina Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.10. Argentina Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.11. Argentina Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.12. Argentina Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.13. Rest of Latin America Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.14. Rest of Latin America Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.15. Rest of Latin America Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1.16. Rest of Latin America Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Peripheral Vascular Devices Market Outlook, 2019-2032
10.1. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032
10.1.1. Key Highlights
10.1.1.1. Peripheral Vascular Stents
10.1.1.1.1. Self-Expanding Stents
10.1.1.1.2. Balloon Expanding Stents
10.1.1.1.3. Covered Stents
10.1.1.1.4. Drug Eluting Stents
10.1.1.2. Drug Eluting Balloons
10.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
10.2. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
10.2.1. Key Highlights
10.2.1.1. Target Artery Instability (TAI)
10.2.1.2. Access Artery Injury (AAI)
10.2.1.3. Peripheral Arterial Disease
10.2.1.4. Arteriovenous Fistulas
10.2.1.5. Peripheral Aneurysms
10.2.1.6. Others
10.3. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
10.3.1. Key Highlights
10.3.1.1. Carotid Artery
10.3.1.2. Fem-Pop Artery
10.3.1.3. Iliac Artery
10.3.1.4. Infrapop Artery
10.4. Middle East & Africa Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1. Key Highlights
10.4.1.1. Hospitals
10.4.1.2. Ambulatory Surgical Centers/Outpatients
10.4.1.3. Cardiac Catheterization Labs
10.5. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1. Key Highlights
10.5.1.1. GCC Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.2. GCC Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.3. GCC Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.4. GCC Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.5. South Africa Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.6. South Africa Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.7. South Africa Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.8. South Africa Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.9. Egypt Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.10. Egypt Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.11. Egypt Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.12. Egypt Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.13. Nigeria Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.14. Nigeria Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.15. Nigeria Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.16. Nigeria Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.17. Rest of Middle East & Africa Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.18. Rest of Middle East & Africa Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.19. Rest of Middle East & Africa Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1.20. Rest of Middle East & Africa Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Product vs Indication Heatmap
11.2. Company Market Share Analysis, 2025
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Abbott Laboratories
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Boston Scientific Corporation
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Cook Medical Inc.
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. MicroPort Scientific Corporation (Endovastec™)
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Medtronic Plc.
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. Cardinal Health, Inc
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. B. Braun Melsungen AG
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. BIOTRONIK SE & Co. KG
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Becton, Dickinson, and Company
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. W. L. Gore & Associates Inc.
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Getinge AB
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
11.4.12. Terumo Corp
11.4.12.1. Company Overview
11.4.12.2. Product Portfolio
11.4.12.3. Financial Overview
11.4.12.4. Business Strategies and Development
11.4.13. Kyoto Medical Planning Co Ltd
11.4.13.1. Company Overview
11.4.13.2. Product Portfolio
11.4.13.3. Financial Overview
11.4.13.4. Business Strategies and Development
11.4.14. iVascular S.L.U
11.4.14.1. Company Overview
11.4.14.2. Product Portfolio
11.4.14.3. Financial Overview
11.4.14.4. Business Strategies and Development
11.4.15. AMG International GmbH
11.4.15.1. Company Overview
11.4.15.2. Product Portfolio
11.4.15.3. Financial Overview
11.4.15.4. Business Strategies and Development
11.4.16. Endocor GmbH
11.4.16.1. Company Overview
11.4.16.2. Product Portfolio
11.4.16.3. Financial Overview
11.4.16.4. Business Strategies and Development
11.4.17. Meril Life Sciences Pvt. Ltd.
11.4.17.1. Company Overview
11.4.17.2. Product Portfolio
11.4.17.3. Financial Overview
11.4.17.4. Business Strategies and Development
11.4.18. Nano Therapeutics Pvt Ltd
11.4.18.1. Company Overview
11.4.18.2. Product Portfolio
11.4.18.3. Financial Overview
11.4.18.4. Business Strategies and Development
11.4.19. Koninklijke Philips N.V.
11.4.19.1. Company Overview
11.4.19.2. Product Portfolio
11.4.19.3. Financial Overview
11.4.19.4. Business Strategies and Development
11.4.20. REVA Medical
11.4.20.1. Company Overview
11.4.20.2. Product Portfolio
11.4.20.3. Financial Overview
11.4.20.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation (Endovastec™)
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Becton, Dickinson, and Company
  • W. L. Gore & Associates Inc.
  • Getinge AB
  • Terumo Corp
  • Kyoto Medical Planning Co Ltd
  • iVascular S.L.U
  • AMG International GmbH
  • ENDOCOR GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Nano Therapeutics Pvt Ltd
  • Koninklijke Philips N.V.
  • REVA Medical